Results

CARA Therapeutics Inc.

06/30/2022 | Press release | Distributed by Public on 06/30/2022 05:06

Cara Therapeutics Announces Positive Topline Results from KOMFORT Phase 2 Trial of Oral Difelikefalin for the Treatment of Pruritus in Patients with Notalgia Paresthetica